C
Cara Therapeutics
CARA
0.35480
USD
0.0038
(1.08%)
مغلق
حجم التداول
612
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
14,814,077
الأخبار
العنوان: Cara Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.